or Try an Advanced Search...

    Technical Analysis for CUE - Cue Biopharma, Inc.

    Grade Last Price % Change Price Change
    D 1.09 -0.46% -0.01
    CUE closed up 0.93 percent on Wednesday, November 20, 2024, on 46 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CUE trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish -0.46%
    MACD Bearish Centerline Cross Bearish -0.46%
    NR7 Range Contraction -0.46%
    Narrow Range Bar Range Contraction -0.46%
    Lower Bollinger Band Walk Weakness -0.46%
    Inside Day Range Contraction -0.46%
    Wide Bands Range Expansion -0.46%
    Lower Bollinger Band Touch Weakness -0.46%
    Oversold Stochastic Weakness -0.46%
    50 DMA Resistance Bearish 0.46%
    Older End-of-Day Signals for CUE ...

       Recent Intraday Alerts

    Alert Time
    Down 5% 28 minutes ago
    Lower Bollinger Band Support 28 minutes ago
    Down 3% about 3 hours ago
    Fell Below Previous Day's Low about 3 hours ago
    Down 2 % about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CUE Chart by TradingView
    Basic chart:

    Profile

    Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Immune System Pharmacy Medication Autoimmunity Specialty Drugs Autoimmune Disorders Immune Disorders

    Is CUE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 17 Cue Biopharma Third Quarter 2024 Earnings: Beats Expectations
    Nov 15 Cue Biopharma GAAP EPS of -$0.1, revenue of $3.34M
    Nov 14 Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates
    Nov 14 Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
    Nov 14 Cue names Daniel Baker interim CDO, CSO Anish Suri to transition to advisor role
    Nov 14 Cue Biopharma Announces Strategic Organizational Transition
    Nov 8 Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
    Oct 8 Cue Biopharma (NASDAQ:CUE) adds US$31m to market cap in the past 7 days, though investors from three years ago are still down 89%
    Oct 4 Cue Biopharma stock rallies nearly 40% on upcoming presentations
    Oct 4 Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
    See more CUE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.2491
    52 Week Low 0.45
    Average Volume 887,567
    200-Day Moving Average 1.38
    50-Day Moving Average 1.17
    20-Day Moving Average 1.54
    10-Day Moving Average 1.46
    Average True Range 0.25
    RSI (14) 39.39
    ADX 23.84
    +DI 14.97
    -DI 22.99
    Chandelier Exit (Long, 3 ATRs) 1.25
    Chandelier Exit (Short, 3 ATRs) 1.78
    Upper Bollinger Bands 2.01
    Lower Bollinger Band 1.07
    Percent B (%b) 0.02
    BandWidth 60.84
    MACD Line -0.01
    MACD Signal Line 0.09
    MACD Histogram -0.1007
    Fundamentals Value
    Market Cap 49.18 Million
    Num Shares 45.1 Million
    EPS -1.20
    Price-to-Earnings (P/E) Ratio -0.91
    Price-to-Sales 27.76
    Price-to-Book 2.46
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.27
    Resistance 3 (R3) 1.28 1.22 1.24
    Resistance 2 (R2) 1.22 1.18 1.22 1.23
    Resistance 1 (R1) 1.16 1.15 1.13 1.15 1.22
    Pivot Point 1.10 1.10 1.09 1.10 1.10
    Support 1 (S1) 1.04 1.06 1.01 1.03 0.96
    Support 2 (S2) 0.98 1.03 0.98 0.95
    Support 3 (S3) 0.92 0.98 0.94
    Support 4 (S4) 0.91